- BOTOX® is the First and Only FDA-Approved Neurotoxin Treatment for Both Upper and Lower Limb Spasticity - DUBLIN, Jan. 22, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global ...
The treatment was already approved for pediatric upper limb spasticity earlier this year. This new approval was based on data from a phase 3 trial evaluating the safety and efficacy of Botox in 381 ...
Background OnabotulinumtoxinA has demonstrated significant benefit in adult focal spasticity. This study reviews the injection patterns (i.e., muscle distribution, dosing) of onabotulinumtoxinA for ...
Spasticity is a symptom or complication of many different neurological disorders in which normal muscle movement patterns are disrupted, and muscles contract, or tighten, involuntarily. In a healthy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results